820 Views
Institutional Officials and HRPP Leadership Track
Breakout Session Series E
Keren Dunn, CIP
Associate Director, Research Compliance & Quality Improvement
Cedars-Sinai Medical Center
F. Lisa Murtha, Esq., CHC, CHRC
Senior Managing Director and Practice Leader
FTI Consulting
Ann Rodavitch, MA
Director Protocol Activation, Review and Human Research Protection Program
Memorial Sloan Kettering Cancer Center
In an increasingly complex clinical research environment, HRPPs must recognize the importance of accurate and appropriate clinical trial billing both in the context of minimizing financial harm to human subjects involved in research, as well as promoting and maintaining institutional regulatory compliance. During this session, speakers and attendees will: